Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

OLPRUVA

SODIUM PHENYLBUTYRATE

Standard Dose
6GM/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview OLPRUVA is listed in Drugs@FDA under application 214860 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM PHENYLBUTYRATE Form and strength FOR SUSPENSION;ORAL - 6GM/PACKET Sponsor ACER Submission history Latest submission status date: 2025-10-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview OLPRUVA is listed in Drugs@FDA under application 214860 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM PHENYLBUTYRATE Form and strength FOR SUSPENSION;ORAL - 6GM/PACKET Sponsor ACER Submission history Latest submission status date: 2025-10-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.